πŸŽ“ Free with any module membership

Cross-Training: Imaging Modalities

Understand how ultrasound fits into the bigger diagnostic picture. Compare US with CT, MRI, Nuclear Medicine, Mammography, and X-ray β€” and learn the registry keywords that connect them all.

Why Cross-Training Matters for the ARDMS Registry

The ARDMS registry exams don't test ultrasound in isolation. Questions frequently reference other imaging modalities and how they relate to sonographic findings. You'll encounter scenarios where a CT finding triggers an ultrasound follow-up, an MRI confirms what you saw on US, or a nuclear medicine study provides functional data that complements your anatomic scan.

This module teaches you to recognize how imaging modalities work together in clinical practice β€” the same way the registry tests it. No practice questions here, just the knowledge foundation you need to understand the cross-references.

What You'll Learn

πŸ”¬

Modality Fundamentals

How CT, MRI, Nuclear Medicine, Mammography, and X-ray actually work β€” enough to understand registry questions, not to become a radiologist.

πŸ”„

Clinical Pathways

Real-world diagnostic workflows: when US leads to CT, when MRI follows US, when nuclear medicine triggers echo β€” and why.

πŸ“Š

Side-by-Side Comparisons

How the same pathology looks on US vs CT vs MRI. Pattern recognition across modalities builds deeper understanding.

πŸ”‘

Registry Keywords

Specific terms and phrases from other modalities that appear on ARDMS exams. Know them before test day.

πŸ“‹

Case Studies

Multi-modality workups showing the complete diagnostic journey β€” from initial presentation through imaging to diagnosis.

πŸ“–

Medical Terminology

Roots, prefixes, and suffixes that appear across all imaging reports. Decode any term on the registry.

Imaging Modalities at a Glance

Each modality uses different physics to create images. Understanding the basics helps you interpret registry questions that reference other studies.

πŸ”Š

Ultrasound (US)

Physics: Sound waves (2-18 MHz) reflected at tissue interfaces. Real-time, portable, no radiation. Operator-dependent.

Best for: Soft tissue, fluid vs solid, real-time motion, Doppler flow, fetal imaging, bedside/POCUS.

Limitations: Body habitus, bowel gas, operator skill, limited by bone/air interfaces.

Your specialty
πŸ’«

Computed Tomography (CT)

Physics: X-ray tube rotates around patient; detectors measure attenuation. Hounsfield units (HU) quantify density.

Best for: Trauma, lung, bone, hemorrhage, vascular (CTA), rapid whole-body survey. Excellent spatial resolution.

Limitations: Ionizing radiation, IV contrast risks (allergy, renal), limited soft tissue contrast vs MRI.

Ionizing radiation
🧲

Magnetic Resonance Imaging (MRI)

Physics: Strong magnetic field aligns hydrogen protons; RF pulses and gradient fields create signal. T1, T2, FLAIR, DWI sequences.

Best for: Soft tissue contrast (brain, spine, joints, liver characterization), no radiation. Gold standard for many pathologies.

Limitations: Slow, expensive, claustrophobia, contraindicated with some implants, gadolinium risks (NSF).

No radiation
☒️

Nuclear Medicine (NM)

Physics: Radiotracer injected IV; gamma camera detects emitted photons. Shows function not just anatomy. SPECT and PET.

Best for: Thyroid (I-123), cardiac perfusion (Tc-99m), bone mets (Tc-99m MDP), hepatobiliary (HIDA), PE (V/Q), PET-CT for cancer staging.

Limitations: Radiation dose, poor spatial resolution, limited anatomy, pregnancy contraindicated.

Functional imaging
🩻

Mammography

Physics: Low-energy X-rays (25-35 kVp) through compressed breast. Digital (FFDM) and tomosynthesis (DBT, 3D).

Best for: Breast cancer screening, calcifications (micro/macro), architectural distortion. BI-RADS classification.

Limitations: Dense breast tissue reduces sensitivity, radiation, compression discomfort, lower sensitivity in young women.

Screening standard
πŸ“·

X-ray (Radiography)

Physics: Single X-ray beam through body onto detector. 2D projection of 3D anatomy. Density: air→fat→soft tissue→bone→metal.

Best for: Fractures, pneumonia, CHF (cardiomegaly, pulmonary edema), foreign bodies, bowel obstruction, lines/tubes.

Limitations: 2D only, limited soft tissue detail, superimposition of structures, radiation.

First-line imaging

Key Physics Comparisons for the Registry

PropertyUSCTMRINuclear
Energy sourceSound wavesX-raysRF + magnetic fieldRadiotracer (Ξ³-rays)
RadiationNone (ALARA still applies β€” thermal/mechanical)Yes (ionizing)NoneYes (ionizing)
Contrast agentMicrobubbles (Definity, Lumason)Iodinated IVGadolinium IVRadiotracer IV
Spatial resolutionGood (axial 0.5-1mm)Excellent (<1mm)Good (1-2mm)Poor (6-10mm)
Temporal resolutionExcellent (real-time)Good (gated)Poor (seconds)Poor (minutes)
Soft tissue contrastModerateModerateExcellentN/A (functional)
Pregnancy safe?Yes (diagnostic levels)No (avoid)Relative (no gadolinium)No
CostLowModerateHighHigh
PortabilityExcellent (bedside)None (fixed)None (fixed)None (fixed)

Cardiac Workup Pathways

πŸ«€ Chest Pain / Suspected CAD

EKG + Troponin β†’ Stress Test (Exercise/Pharmacologic) β†’ Stress Echo (wall motion analysis) β†’ Nuclear Stress (Tc-99m perfusion defect) β†’ Coronary CTA or Cath

Registry connection: A nuclear stress test showing a "reversible perfusion defect" = ischemia. This patient may then get a stress echo to assess wall motion. A "fixed defect" = old infarct/scar. Echo would show regional wall motion abnormality (akinesis/dyskinesis) in the corresponding territory.

πŸ«€ Heart Failure Evaluation

CXR (cardiomegaly, edema) β†’ BNP/NT-proBNP β†’ Echocardiogram (EF, diastolic function, valves) β†’ Cardiac MRI (viability, infiltrative disease) β†’ Nuclear (MUGA for precise EF)

Registry connection: CXR shows "cephalization of vessels" and "Kerley B lines" = pulmonary edema from CHF. Echo quantifies LVEF (HFrEF ≀40%, HFpEF β‰₯50%). Cardiac MRI with late gadolinium enhancement (LGE) shows fibrosis/scar pattern β€” subendocardial = ischemic, mid-wall = non-ischemic (myocarditis, HCM). MUGA scan gives most reproducible EF (used for chemo monitoring).

πŸ«€ Valvular Heart Disease

Murmur on exam β†’ TTE (severity grading) β†’ TEE (detailed valve morphology) β†’ Cardiac CT (annular sizing for TAVR) β†’ Cardiac Cath (hemodynamics)

Registry connection: TTE is the first-line for all valve disease. TEE provides higher-resolution views (especially MV, LA appendage, prosthetic valves). Cardiac CT measures aortic annulus dimensions for TAVR sizing β€” you may see "annular calcium" or "CT-derived annulus" on the registry. Cardiac cath provides invasive hemodynamic confirmation when echo and symptoms are discordant.

πŸ«€ Pulmonary Embolism

D-dimer + Wells score β†’ CT Pulmonary Angiogram (CTPA) β†’ Echo (RV strain, McConnell sign) β†’ Lower extremity venous duplex (DVT source) β†’ V/Q scan (if CTA contraindicated)

Registry connection: CTPA is gold standard for PE diagnosis. Echo in massive PE shows RV dilation, septal bowing, McConnell sign (RV free wall akinesis with apical sparing), and elevated RVSP. The venous duplex is ordered to find the DVT source. V/Q scan (nuclear) is alternative when CTA is contraindicated β€” "high probability V/Q" = mismatched perfusion defect.

Abdominal / Hepatobiliary Pathways

🫁 Liver Mass Workup

US (initial detection) β†’ Contrast-enhanced CT (arterial/portal/delayed phases) β†’ MRI with Eovist/Primovist (hepatocyte-specific agent) β†’ Biopsy (if indeterminate)

Registry connection: US often detects the mass first. CT/MRI characterizes it: hemangioma shows peripheral nodular enhancement filling in centripetally. HCC shows arterial enhancement + portal venous washout + enhancing capsule (LI-RADS criteria). FNH has a central scar that enhances on delayed phase. "Washout" and "arterial enhancement" are registry keywords.

🫁 RUQ Pain (Gallbladder)

RUQ Ultrasound (first-line) β†’ HIDA scan (if US equivocal for acute cholecystitis) β†’ MRCP (CBD stones, pancreatic duct) β†’ ERCP (therapeutic β€” stone removal)

Registry connection: US is first-line for RUQ pain (stones, wall thickening, Murphy sign, CBD dilation). HIDA scan (nuclear, Tc-99m DISIDA) shows non-visualization of gallbladder = acute cholecystitis (cystic duct obstruction). MRCP (MRI) is non-invasive to evaluate CBD/pancreatic duct without contrast or radiation. ERCP is both diagnostic and therapeutic (can remove stones, place stents).

🫁 Renal Mass

US (cyst vs solid, Bosniak) β†’ CT with contrast (Bosniak classification) β†’ MRI (indeterminate lesions) β†’ Biopsy or surgery

Registry connection: US identifies simple cyst (Bosniak I: anechoic, thin wall, posterior enhancement) vs complex/solid. CT Bosniak classification uses enhancement (>20 HU change): I = simple cyst, II = minimally complex, IIF = follow-up, III = indeterminate (surgery considered), IV = clearly malignant. RCC on CT shows heterogeneous enhancement. "Hounsfield units" and "enhancement" are registry keywords.

🫁 Aortic Aneurysm Surveillance

US (screening, surveillance) β†’ CTA (pre-surgical planning) β†’ Surgery/EVAR (if meets criteria)

Registry connection: US is the screening and surveillance tool for AAA (β‰₯3 cm). CTA provides exact dimensions, branch vessel anatomy, and planning for endovascular repair (EVAR). US measures AP diameter outer-to-outer. CT measures in multiple planes. Repair threshold: β‰₯5.5 cm or rapid growth >0.5 cm/6 months.

OB/GYN Pathways

🀰 First Trimester Bleeding

Ξ²-hCG level β†’ Transvaginal US β†’ Serial Ξ²-hCG (if indeterminate) β†’ MRI (for ectopic variants β€” CSP, cervical)

Registry connection: TV US is the primary imaging for first-trimester bleeding. Discriminatory hCG level (~1500-2000 mIU/mL): above this, IUP should be visible on TV US. If no IUP seen β†’ ectopic pregnancy workup. MRI may be used for unusual ectopic implantation sites (c-section scar pregnancy, cervical ectopic).

🩺 Breast Mass Workup

Mammogram (screening) β†’ Breast US (targeted to mammo finding) β†’ Breast MRI (high-risk screening, extent of disease) β†’ US-guided biopsy or stereotactic biopsy

Registry connection: Mammography detects calcifications that US cannot see. US differentiates cyst from solid and guides biopsy. Breast MRI has highest sensitivity but lowest specificity β€” used for high-risk screening (BRCA+), pre-operative extent assessment, and implant evaluation. BI-RADS classification applies to all breast imaging. "Architectural distortion," "spiculated mass," and "grouped microcalcifications" are registry keywords from mammography.

Vascular & MSK Pathways

🦡 DVT / PE Workup

Wells score β†’ Compression US (2-point or whole-leg) β†’ CTPA (if PE suspected) β†’ CT Venography (combined with CTPA)

Registry connection: Compression US is first-line for DVT. Non-compressibility = positive DVT. CTPA is gold standard for PE. CT venography can be done in the same sitting as CTPA β€” the contrast is already in the veins. MR venography is an alternative for contrast-allergic patients.

🦴 Rotator Cuff Tear

X-ray (rule out fracture) β†’ US (dynamic evaluation, tears, tendinosis) β†’ MRI (gold standard for surgical planning) β†’ MR Arthrogram (labral tears)

Registry connection: US has sensitivity comparable to MRI for full-thickness rotator cuff tears (>90% in experienced hands). US advantage: dynamic evaluation, contralateral comparison, guided injection, lower cost. MRI advantage: full field of view, bone marrow, labrum, better for partial tears and surgical planning. "Full-thickness tear" vs "partial-thickness tear" vs "tendinosis" are critical distinctions on the registry.

How the Same Pathology Looks Across Modalities

Understanding appearance differences helps you answer registry questions that describe findings on other studies and ask what you'd expect on ultrasound.

Liver Hemangioma

πŸ”Š On Ultrasound

Hyperechoic, well-circumscribed, homogeneous. Posterior acoustic enhancement. No internal vascularity on color Doppler. Typical location: right lobe, posterior.

US appearance

πŸ’« On CT

Hypodense on non-contrast. Peripheral nodular enhancement on arterial phase with progressive centripetal fill-in on portal/delayed phases. Complete fill-in on delayed = diagnostic.

CT appearance

🧲 On MRI

Very bright on T2 ("light bulb sign"). T1 hypointense. Same peripheral nodular enhancement pattern as CT. MRI is confirmatory when US is atypical.

MRI appearance
Peripheral nodular enhancement Centripetal fill-in Light bulb sign (T2) Hyperechoic Posterior enhancement

Hepatocellular Carcinoma (HCC)

πŸ”Š On Ultrasound

Variable echogenicity (hypo/iso/hyperechoic). Heterogeneous mass in cirrhotic liver. May show "halo" sign (hypoechoic rim = pseudocapsule). Hepatic vein/portal vein invasion.

US appearance

πŸ’« On CT

Arterial enhancement (hypervascular) + portal venous washout + enhancing capsule = LI-RADS 5 (definite HCC). No biopsy needed if criteria met in at-risk patient.

CT appearance

🧲 On MRI

Same enhancement pattern as CT. MRI more sensitive for small lesions. Diffusion restriction on DWI. Eovist (hepatocyte-specific contrast) shows hypointense on hepatobiliary phase = diagnostic.

MRI appearance
Arterial enhancement Portal venous washout LI-RADS Pseudocapsule / halo sign Cirrhotic liver

Gallstones vs Choledocholithiasis

πŸ”Š On Ultrasound

GB stones: echogenic foci + posterior shadow + gravity-dependent. CBD stones: dilated CBD (>6mm) Β± visible stone. US sensitivity for CBD stones is only 50-70%.

US appearance

🧲 On MRCP

CBD stones appear as dark filling defects within bright bile on T2. MRCP sensitivity >95% for CBD stones. Non-invasive, no contrast needed.

MRI appearance

☒️ On HIDA

Non-visualization of gallbladder at 4 hours (with CCK/morphine augmentation) = acute cholecystitis. GB ejection fraction <35% = biliary dyskinesia.

Nuclear appearance
HIDA scan non-visualization MRCP filling defect GB ejection fraction Choledocholithiasis Cholecystitis

Renal Cell Carcinoma

πŸ”Š On Ultrasound

Solid heterogeneous renal mass. May be iso/hyper/hypoechoic. Internal vascularity on color Doppler. Check for IVC extension (tumor thrombus).

US appearance

πŸ’« On CT

Enhancing solid mass (>20 HU enhancement). Heterogeneous. May contain calcification, necrosis. CT defines TNM staging, IVC involvement, lymph nodes, mets.

CT appearance

🧲 On MRI

T2 hyperintense, enhancing. MRI better for characterizing indeterminate renal lesions (hemorrhagic cyst vs solid). DWI restriction in malignancy.

MRI appearance

Aortic Aneurysm

πŸ”Š On Ultrasound

AP diameter measured outer wall to outer wall. Mural thrombus appears echogenic. Cannot reliably see suprarenal extent or iliac involvement.

US appearance

πŸ’« On CTA

Complete visualization: exact dimensions in all planes, branch vessel anatomy, iliac extension, mural thrombus, signs of impending rupture (crescent sign, draped aorta).

CT appearance

Carotid Stenosis

πŸ”Š On Duplex US

B-mode plaque characterization + Doppler velocities (PSV, EDV, ICA/CCA ratio). SRU consensus criteria for stenosis grading. Dynamic, real-time, no contrast.

US appearance

πŸ’« On CTA

Luminal narrowing measured by NASCET criteria (1 - residual lumen / distal ICA Γ— 100). Calcified vs soft plaque. Visualization of intracranial circulation.

CT appearance

🧲 On MRA

Time-of-flight (TOF) or contrast-enhanced MRA. Can overestimate stenosis (flow gap artifact). Used when CTA contraindicated or for intracranial vessels.

MRI appearance
NASCET criteria SRU consensus PSV >230 = 70-99% Stenosis grading

Breast Masses

πŸ”Š On Ultrasound

Cyst vs solid differentiation. Benign: oval, parallel, circumscribed, no vascularity. Suspicious: irregular, taller-than-wide, angular margins, posterior shadowing.

US appearance

🩻 On Mammography

Mass characteristics: shape, margins, density. Calcifications: benign (coarse, popcorn, eggshell) vs suspicious (fine pleomorphic, linear branching). Architectural distortion.

Mammo appearance

🧲 On Breast MRI

Enhancement kinetics: type I (persistent = benign), type II (plateau = indeterminate), type III (washout = suspicious). Highest sensitivity for invasive cancer.

MRI appearance
BI-RADS classification Taller-than-wide Type III kinetics (washout) Architectural distortion Fine pleomorphic calcifications

Thyroid Nodules

πŸ”Š On Ultrasound

TI-RADS scoring: composition, echogenicity, shape, margin, echogenic foci. Suspicious: solid hypoechoic, taller-than-wide, irregular margins, microcalcifications.

US appearance

☒️ On Nuclear (I-123)

"Hot" nodule (hyperfunctioning) = almost always benign. "Cold" nodule (non-functioning) = higher cancer risk β†’ needs FNA. Thyroid scan determines function.

Nuclear appearance
Hot nodule vs cold nodule TI-RADS Microcalcifications Hyperfunctioning

Multi-Modality Case Studies

Each case traces the complete diagnostic journey, showing how different imaging modalities complement each other.

Case 1: 65-year-old Male β€” Chest Pain on Exertion

PMH: HTN, DM, smoker. Presenting complaint: substernal chest pressure with exercise Γ— 3 weeks.

Step 1: Initial Workup

EKG: normal sinus rhythm, no acute ST changes. Troponin: negative Γ— 2. CXR: mild cardiomegaly, no pulmonary edema.

CXR keyword: "Cardiomegaly" = CTR >0.5 on PA film. Triggers echocardiogram to assess LV size and function.
Step 2: Nuclear Stress Test (Tc-99m Sestamibi)

Exercise treadmill to 85% MPHR. Nuclear perfusion imaging shows reversible perfusion defect in the anteroseptal and apical segments.

Registry keyword: "Reversible perfusion defect" = ischemia (stress-induced, recovers at rest). "Fixed defect" = completed infarct/scar.
Step 3: Stress Echocardiogram (Follow-up)

Rest: normal wall motion, LVEF 58%. Peak stress: new hypokinesis of the anterior wall and anteroseptal segments (LAD territory). Basal inferior wall hyperdynamic (compensatory).

Echo correlation: The nuclear perfusion defect in anteroseptal/apical segments matches the echo wall motion abnormality. Both point to LAD territory ischemia.
Step 4: Coronary CTA (or Cath)

CTA reveals 80% stenosis of the mid-LAD with mixed plaque (calcified + soft). Referred for cardiac catheterization and stent placement.

Cross-modality learning: Nuclear shows perfusion (function). Echo shows wall motion (mechanical). CT/cath shows anatomy. All three converge on the same diagnosis: significant LAD stenosis causing ischemia.

Case 2: 52-year-old Female β€” Incidental Liver Lesion

PMH: healthy. CT abdomen for unrelated reason reveals 3 cm liver lesion. Referred for ultrasound correlation.

Step 1: CT Finding

Contrast-enhanced CT shows a 3 cm well-circumscribed lesion in the right hepatic lobe, segment VI. Peripheral nodular enhancement on arterial phase with progressive centripetal fill-in on portal venous and delayed phases.

CT keyword: "Peripheral nodular enhancement with centripetal fill-in" is pathognomonic for hemangioma on CT. But the clinician wants US correlation.
Step 2: Liver Ultrasound

US shows a well-circumscribed, hyperechoic, homogeneous mass in segment VI with posterior acoustic enhancement. No internal vascularity on color Doppler.

US correlation: Classic hemangioma on US = hyperechoic, homogeneous, well-defined, posterior enhancement, no flow. Matches the CT diagnosis.
Step 3: MRI Confirmation (if atypical)

If the US appearance were atypical (e.g., hypoechoic in a fatty liver), MRI would be ordered. Hemangioma on MRI: very bright T2 ("light bulb sign"), same enhancement pattern as CT.

Key takeaway: Many liver lesions are detected incidentally on CT. US is often the next step for correlation. When both agree, diagnosis is confirmed without biopsy. MRI is the tiebreaker.

Case 3: 28-year-old Female β€” Pelvic Pain + Positive hCG

PMH: prior ectopic pregnancy, IUD removed 3 months ago. Ξ²-hCG: 2,800 mIU/mL.

Step 1: Transvaginal Ultrasound

No intrauterine pregnancy (IUP) seen. Endometrial stripe measures 12 mm (thickened, "pseudodecidual reaction"). Right adnexa: 2 cm complex mass with a hyperechoic ring ("tubal ring sign"). Small amount of free fluid in the cul-de-sac.

US finding: Empty uterus + adnexal mass + free fluid at hCG above discriminatory level = ectopic pregnancy until proven otherwise. "Tubal ring sign" is pathognomonic.
Step 2: Clinical Decision

With hCG >2,000 (above discriminatory level for TV US) and no IUP, this is an ectopic pregnancy. Patient is hemodynamically stable β†’ medical management with methotrexate is considered.

Registry connection: Know the discriminatory hCG level (~1,500-2,000 TV, ~6,500 TA). If hCG is above this and no IUP is seen, ectopic is presumed. "Pseudodecidual reaction" = decidualized endometrium without gestational sac. "Ring of fire" on Doppler = peripheral vascularity around ectopic.
Step 3: MRI (if C-section scar ectopic suspected)

In unusual locations (c-section scar, cervical, interstitial), MRI helps delineate the relationship of the ectopic to the myometrium and surrounding structures for surgical planning.

Case 4: 70-year-old Male β€” Carotid Bruit + TIA

PMH: HTN, hyperlipidemia. Episode of right arm weakness and speech difficulty lasting 20 minutes (TIA).

Step 1: Carotid Duplex Ultrasound

Left ICA: heterogeneous plaque at the bulb with ulceration. PSV 285 cm/s, EDV 122 cm/s, ICA/CCA ratio 4.8. Classified as 70-99% stenosis per SRU consensus criteria.

US finding: Meets criteria for severe stenosis (PSV >230, EDV >100, ratio >4.0). Heterogeneous plaque with ulceration = high embolic risk ("vulnerable plaque").
Step 2: CTA Head/Neck

Confirms severe left ICA stenosis at 78% by NASCET criteria. No intracranial occlusion. Good collateral flow via Circle of Willis.

Registry keyword: NASCET criteria measures stenosis as (1 - residual lumen Γ· distal ICA diameter) Γ— 100. Different from ECST criteria. Know both for the registry.
Step 3: Surgical Decision

Symptomatic stenosis >70% = carotid endarterectomy (CEA) or carotid artery stenting (CAS) recommended per guidelines. Post-operative duplex surveillance at 30 days, 6 months, then annually.

Cross-modality: US is the screening and surveillance tool. CTA/MRA confirms and provides surgical road map. Post-CEA velocity criteria differ from native carotid (PSV >150 may indicate restenosis in a CEA patient vs >125 in native ICA).

Case 5: 45-year-old Female β€” Breast Mass on Screening Mammogram

No symptoms. Routine screening mammogram (age-appropriate). BIRADS 0 β€” incomplete, needs additional imaging.

Step 1: Screening Mammogram

A 1.5 cm oval mass with partially obscured margins identified in the upper outer quadrant of the right breast. No calcifications. Dense breast tissue (ACR density C).

Mammo keyword: "Partially obscured margins" = not clearly benign, needs US for further characterization. BI-RADS 0 = needs additional imaging.
Step 2: Targeted Breast Ultrasound

Correlating mass at 10 o'clock, 5 cm from nipple: 1.4 cm oval, parallel, circumscribed, hypoechoic solid mass with no posterior features. No internal vascularity.

US finding: Oval + parallel + circumscribed = probably benign features. BI-RADS 3 = probably benign, short-interval follow-up (6 months) recommended. If any suspicious feature (taller-than-wide, irregular, angular margins) β†’ BI-RADS 4 β†’ biopsy.
Step 3: If Suspicious Features

If the mass were taller-than-wide, irregular, or had posterior shadowing, it would be BI-RADS 4 (suspicious). US-guided core needle biopsy would be performed. If calcifications are the concern and not visible on US, stereotactic mammographic biopsy is used instead.

Key concept: Mammography sees calcifications better than US. US differentiates cyst from solid better than mammography. MRI has highest sensitivity for invasive cancer. Each modality has its role β€” the registry tests this understanding.

Registry Keywords from Other Modalities

These terms from CT, MRI, Nuclear Medicine, and Mammography appear on ARDMS exams. Know what they mean and how they connect to ultrasound findings.

CT Keywords

TermMeaningUS Connection
Hounsfield Units (HU)CT density measurement. Water=0, air=-1000, bone=+1000, fat=-100, soft tissue=+40-60US uses echogenicity instead (anechoic, hypo, iso, hyperechoic)
Arterial enhancementLesion becomes bright on arterial phase CT = hypervascularOn US: increased vascularity on color Doppler
Portal venous washoutLesion becomes darker than liver on portal phase = suspicious for HCCUS: cannot directly assess enhancement, but can see flow characteristics
LI-RADSLiver Imaging Reporting and Data System for HCC in at-risk patientsUS LI-RADS (CEUS) is a separate scoring system using contrast-enhanced US
Bosniak classificationCT classification of renal cysts (I-IV) based on septations, enhancement, calcificationUS can identify simple cysts (Bosniak I) but CT needed for enhancement assessment
NASCET criteriaNorth American method to measure carotid stenosis on CTA: (1βˆ’residual/distal ICA)Γ—100US uses velocity criteria (SRU consensus) which correlate with NASCET percentages
Ground glass opacityHazy lung opacity on CT (inflammation, infection, hemorrhage)US: B-lines (lung ultrasound) correspond to interstitial edema, correlate with CT GGO in some settings
Crescent signHigh-attenuation crescent in AAA wall = acute/impending ruptureUS: may see echogenic focus in mural thrombus, but CT is definitive for rupture signs

MRI Keywords

TermMeaningUS Connection
T1-weightedFat = bright, fluid = dark. Good for anatomy. "T1 = fat is fine"US: fat is hyperechoic (similar concept)
T2-weightedFluid = bright, muscle = dark. Good for pathology/edema. "T2 = water is white"US: fluid is anechoic (black). Opposite brightness convention
DWI (diffusion-weighted)Restricted diffusion = bright. Indicates high cellularity (tumor, abscess, acute stroke)No direct US equivalent, but abscess on US is complex fluid collection
Late gadolinium enhancement (LGE)Bright areas on delayed cardiac MRI = fibrosis/scar. Pattern distinguishes ischemic vs non-ischemicEcho: regional wall motion abnormality corresponds to LGE distribution. Strain imaging (GLS) correlates with fibrosis
Light bulb signVery bright T2 signal in liver hemangioma = diagnosticUS: hemangioma is hyperechoic, homogeneous. Different appearance but same diagnosis
Central scarFNH shows a central scar that enhances on delayed phaseUS: FNH is subtle, near-isoechoic, may see central scar as hyperechoic line
NSF (nephrogenic systemic fibrosis)Rare gadolinium contrast reaction in patients with severe renal failure (GFR <30)US contrast (microbubbles) does NOT cause NSF β€” advantage of CEUS in renal failure patients

Nuclear Medicine Keywords

TermMeaningUS Connection
Reversible perfusion defectArea of reduced perfusion on stress that normalizes at rest = ischemiaStress echo: corresponding new WMA at peak stress that wasn't present at rest
Fixed perfusion defectArea of reduced perfusion on both stress and rest = old infarct/scarEcho: resting WMA (akinesis/thinning) in the same territory = chronic MI
MUGA scanNuclear ventriculography β€” most reproducible LVEF measurementEcho EF by Simpson biplane is the standard. MUGA used when echo windows are poor or for chemo monitoring
HIDA non-visualizationGallbladder doesn't fill with radiotracer at 4 hours = acute cholecystitisUS: stones + thick wall + Murphy sign + pericholecystic fluid = cholecystitis. HIDA confirms when US is equivocal
Hot nodule (thyroid)Hyperfunctioning thyroid nodule on I-123 scan β€” almost always benignUS cannot determine function. A suspicious-appearing nodule on US that is "hot" on nuclear may NOT need biopsy
Cold nodule (thyroid)Non-functioning thyroid nodule β€” higher cancer risk, needs FNAUS-guided FNA is performed on suspicious cold nodules. TI-RADS helps decide which need biopsy
V/Q mismatchVentilation-perfusion scan: perfusion defect without ventilation defect = high probability PEEcho in PE: RV dilation, TR, McConnell sign. Venous duplex may show DVT source
Bone scan (Tc-99m MDP)Increased uptake = osteoblastic activity (metastasis, fracture, infection, Paget disease)US role: guide biopsy of soft tissue component, assess associated soft tissue mass

Mammography Keywords

TermMeaningUS Connection
BI-RADSBreast Imaging Reporting standardized classification (0-6)US uses the same BI-RADS categories. Know what each number means
Architectural distortionDistortion of breast tissue without a visible mass β€” suspicious for cancer or radial scarUS may show irregular hypoechoic area at the site, or may be occult on US (mammo-only finding)
MicrocalcificationsTiny calcifications that may indicate DCIS. Fine pleomorphic or linear branching = suspiciousUS generally CANNOT see microcalcifications. If the lesion is calcification-only, stereotactic biopsy (not US-guided) is needed
Spiculated massMass with radiating lines from margin = highly suspicious for malignancyUS: corresponding irregular, hypoechoic, non-parallel mass with angular margins and posterior shadowing
ACR densityA (fatty) β†’ D (extremely dense). Dense breasts reduce mammo sensitivityUS is more sensitive in dense breasts (ACR C-D). Supplemental screening US recommended for dense-breast patients
Skin thickening / trabecular thickeningMay indicate inflammatory breast cancer or lymphatic obstructionUS: skin thickening >2mm, edema pattern, enlarged axillary lymph nodes

Medical Terminology for the Registry

Understanding word roots, prefixes, and suffixes lets you decode unfamiliar terms on the exam. If you can break apart a word, you can figure out its meaning even if you've never seen it before.

Common Prefixes

PrefixMeaningExample
hyper-Excessive, above normalHyperechoic (brighter than surrounding tissue), hypertension, hyperthyroid
hypo-Deficient, below normalHypoechoic (darker than surrounding tissue), hypotension, hypothyroid
an-/a-Without, absence ofAnechoic (no echoes = black), anemia, amenorrhea, anencephaly
iso-Equal, sameIsoechoic (same echogenicity as reference tissue)
poly-Many, excessivePolyhydramnios (too much amniotic fluid), polycystic, polyuria
oligo-Few, deficientOligohydramnios (too little fluid), oliguria
dys-Difficult, abnormalDysplasia (abnormal development), dyspnea, dysuria
tachy-FastTachycardia (fast heart rate >100 bpm)
brady-SlowBradycardia (slow heart rate <60 bpm)
peri-AroundPericardial (around the heart), perinephric, periportal
retro-Behind, backwardRetroperitoneal (behind peritoneum), retroplacental
endo-WithinEndometrium (inner lining), endocardium, endovascular
echo-Reflected soundEchogenic (producing echoes), echolucent (same as anechoic)
sono-SoundSonography, sonolucent, sonographer
hemo-/hemato-BloodHematoma (blood collection), hemorrhage, hemolysis
hepato-LiverHepatomegaly (enlarged liver), hepatocellular, hepatopetal (toward liver)
nephro-/reno-KidneyNephromegaly, nephrolithiasis (kidney stones), renovascular
cholecyst-GallbladderCholecystitis (GB inflammation), cholecystectomy (GB removal)
choledocho-Common bile ductCholedocholithiasis (CBD stone), choledochal (relating to CBD)

Common Suffixes

SuffixMeaningExample
-itisInflammationCholecystitis, appendicitis, pancreatitis, endocarditis
-osisCondition, abnormal stateStenosis (narrowing), cirrhosis, thrombosis, fibrosis
-ectasisDilation, expansionBronchiectasis, pyelectasis (dilated renal pelvis), atelectasis
-megalyEnlargementHepatomegaly, splenomegaly, cardiomegaly
-pathyDiseaseCardiomyopathy, nephropathy, neuropathy
-omaTumor/massHemangioma, hepatoma (HCC), carcinoma, fibroma
-lithiasisStonesCholelithiasis (gallstones), nephrolithiasis (kidney stones)
-ectomySurgical removalCholecystectomy, nephrectomy, appendectomy
-plastySurgical repairAngioplasty, valvuloplasty
-scopy/-graphyVisual examination / recordingEchocardiography, sonography, mammography, angiography
-peniaDeficiencyThrombocytopenia (low platelets), leukopenia
-stasisStopping, standing stillHemostasis (stopping bleeding), cholestasis (bile stasis)
-emesisVomitingHematemesis (vomiting blood), hyperemesis

Body System Roots

RootMeaningExample in Sonography
cardi/oHeartEchocardiography, cardiomyopathy, pericardial
angi/o, vas/oVesselAngiography, vascular, angioplasty
ather/oFatty plaqueAtherosclerosis (plaque in arteries)
thromb/oClotThrombosis (clot formation), thrombus, thromboembolism
gastr/oStomachGastroschisis (abdominal wall defect), gastric
enter/oIntestineMesentery, enterocolitis (NEC)
cyst/oBladder, sacCholecystitis, cystic (relating to cysts), polycystic
uter/o, metr/o, hyster/oUterusEndometrium, myometrium, hysterectomy
oophor/o, ovari/oOvaryOophorectomy, ovarian torsion
salping/oFallopian tubeSalpingitis, hydrosalpinx
orch/o, test/oTestisOrchitis, cryptorchidism (undescended testis)
encephal/oBrainEncephalocele, anencephaly, holoprosencephaly
oste/oBoneOsteogenesis imperfecta, osteoporosis
my/oMuscleMyocardium (heart muscle), myometrium (uterine muscle)

Directional & Positional Terms

TermMeaningClinical Use
Anterior / PosteriorFront / BackAnterior placenta, posterior acoustic enhancement
Superior / InferiorAbove / BelowSuperior mesenteric artery, inferior vena cava
Medial / LateralToward midline / Away from midlineMedial epicondyle, lateral ventricle
Proximal / DistalCloser to / Farther from originProximal ICA stenosis, distal DVT
Superficial / DeepNear surface / Away from surfaceSuperficial femoral vein, deep venous thrombosis
SagittalLengthwise (head-to-toe) planeSagittal view of aorta, sagittal uterus
Transverse (axial)Cross-section planeTransverse view of carotid, transverse cervix
CoronalFront-to-back dividing planeCoronal view of kidney (long axis), coronal cranial US
Cephalad / CaudadToward head / Toward feetCephalic presentation (head down), caudal regression
Hepatopetal / HepatofugalToward liver / Away from liverPortal vein flow: hepatopetal = normal; hepatofugal = portal HTN